Skip to main content
Top
Published in: Pituitary 4/2018

01-08-2018

Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas

Authors: Isabella P. P. Grande, Paulo V. G. H. Amorim, Ane Caroline Thé B. Freire, Raquel S. Jallad, Nina R. Musolino, Valter A. Cescato, Gilberto O. da Silva, Marcello D. Bronstein, Ericka B. Trarbach

Published in: Pituitary | Issue 4/2018

Login to get access

Abstract

Sirtuins 1–7 (SIRT) are a highly conserved family of histone deacetylases involved in the regulation of longevity that have a considerable impact in transcription, DNA repair regulation, telomeric stability, cell senescence and apoptosis. In the present study, SIRT1–7 mRNA levels were evaluated in 37 somatotropinomas and 31 nonfunctioning pituitary adenomas (NFPAs) using qPCR and relation to tumor size, invasiveness and Ki-67 proliferative index was made. Overexpression of SIRT1 was observed in 86.5% of somatotropinomas versus 41.9% of NFPAs (P < 0.01). SIRT3 was more underexpressed in NFPAs than somatotropinomas (77.4 and 40.5%, respectively, P < 0.01) as well as SIRT4 and SIRT7. Despite the lack of association between sirtuins and invasiveness or Ki-67 index, SIRT1 and SIRT3 expressions were related to tumor size. Mean of the largest diameter was smaller in adenomas with SIRT1 overexpression than with normal expression (P < 0.01) and SIRT3 underexpression was associated with larger tumors (P < 0.01). In conclusion, a pronounced difference in sirtuins expression was identified between pituitary adenomas, suggesting that these genes are potential markers of pituitary adenomas and could be employed in the characterization of somatotropinomas and NFPAs. The role of sirtuins in pathogenesis of pituitary tumors merits further investigation and possibly will provide new molecular insight about their progression.
Literature
3.
go back to reference Pinto EM, Bronstein MD (2008) Molecular aspects of pituitary tumorigenesis. Arq Bras Endocrinol Metabol 52(4):599–610CrossRefPubMed Pinto EM, Bronstein MD (2008) Molecular aspects of pituitary tumorigenesis. Arq Bras Endocrinol Metabol 52(4):599–610CrossRefPubMed
6.
go back to reference Vassilopoulos A, Fritz KS, Petersen DR, Gius D (2011) The human sirtuin family: evolutionary divergences and functions. Hum Genom 5(5):485–496CrossRef Vassilopoulos A, Fritz KS, Petersen DR, Gius D (2011) The human sirtuin family: evolutionary divergences and functions. Hum Genom 5(5):485–496CrossRef
9.
go back to reference Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17(1):41–52. https://doi.org/10.1016/j.ccr.2009.11.023 CrossRefPubMedPubMedCentral Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17(1):41–52. https://​doi.​org/​10.​1016/​j.​ccr.​2009.​11.​023 CrossRefPubMedPubMedCentral
10.
go back to reference Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610–617PubMed Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610–617PubMed
13.
15.
go back to reference Jeong SM, Xiao C, Finley LW, Lahusen T, Souza AL, Pierce K, Li YH, Wang X, Laurent G, German NJ, Xu X, Li C, Wang RH, Lee J, Csibi A, Cerione R, Blenis J, Clish CB, Kimmelman A, Deng CX, Haigis MC (2013) SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23(4):450–463. https://doi.org/10.1016/j.ccr.2013.02.024 CrossRefPubMedPubMedCentral Jeong SM, Xiao C, Finley LW, Lahusen T, Souza AL, Pierce K, Li YH, Wang X, Laurent G, German NJ, Xu X, Li C, Wang RH, Lee J, Csibi A, Cerione R, Blenis J, Clish CB, Kimmelman A, Deng CX, Haigis MC (2013) SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23(4):450–463. https://​doi.​org/​10.​1016/​j.​ccr.​2013.​02.​024 CrossRefPubMedPubMedCentral
Metadata
Title
Differential gene expression of sirtuins between somatotropinomas and nonfunctioning pituitary adenomas
Authors
Isabella P. P. Grande
Paulo V. G. H. Amorim
Ane Caroline Thé B. Freire
Raquel S. Jallad
Nina R. Musolino
Valter A. Cescato
Gilberto O. da Silva
Marcello D. Bronstein
Ericka B. Trarbach
Publication date
01-08-2018
Publisher
Springer US
Published in
Pituitary / Issue 4/2018
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-018-0881-7

Other articles of this Issue 4/2018

Pituitary 4/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.